Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study
Crossref DOI link: https://doi.org/10.1007/s10654-014-9982-4
Published Online: 2014-12-21
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
di Giuseppe, Romina
Kühn, Tilmann
Hirche, Frank
Buijsse, Brian
Dierkes, Jutta
Fritsche, Andreas
Kaaks, Rudolf
Boeing, Heiner
Stangl, Gabriele I.
Weikert, Cornelia
Text and Data Mining valid from 2014-12-21